News
Brief news reports on Tuberculosis
By
R. Prasad
Published: June 23, 2014, 5:36 p.m.·
Tags:
Scientific research
A novel approach adopted by a team of researchers based in Bangalore has opened a window of opportunities to design new antimicrobials that could potentially be used to kill the tuberculosis-causing bacteria.
Read More →
By
IOL
Published: June 23, 2014, 5:32 p.m.·
Tags:
Correctional facilities
Parliament - For every worker who dies each year as a result of an accident on a South African mine, nine more die of tuberculosis, Health Minister Aaron Motsoaledi said on Thursday.
Read More →
By
WHO/Europe
Published: June 23, 2014, 5:18 p.m.·
Tags:
Correctional facilities,
Drug-resistant TB
The newly-appointed WHO Collaborating Centre on Prevention and Control of Tuberculosis in Prisons located in Azerbaijan, is organizing a training course for policy makers and health providers involved in planning and implementation of tuberculosis services in penal institutions of Eastern Europe and Central Asia. The course will take place in Baku, Azerbaijan on 22 - 26 September 2014. Only 15 participants can be accepted. Applications should be sent by 1 August 2014 through the link below.
Read More →
By
TB CAB
Published: June 23, 2014, 4:42 p.m.·
Tags:
TB CAB,
Advocacy
Re: Ensuring the fair administration of the Kochon Prize
Read More →
By
Sipokazi Fokazi
Published: June 22, 2014, 9:05 p.m.·
Tags:
Treatment,
Access,
Drug-resistant TB
Cape Town - Patients with multidrug-resistant (MDR) tuberculosis could soon have access to a promising new drug – Bedaquiline – as the Medicines Control Council (MCC) is “fast-tracking” its authorisation processes to have the drug licensed.
Read More →
By
civil society organizations
Published: June 22, 2014, 8:47 p.m.·
Tags:
None
Over 70 organisations globally have called on the Department of Trade and Industry (DTI) to urgently finalise South Africa's National Intellectual Property (IP) Policy in an open letter delivered today (June 17). You can find a PDF of the open letter here. The Fix the Patent Law campaign thanks all signatories for their support for improving access to medicines in South Africa!
Read More →
By
Christine Lubinski
Published: June 22, 2014, 8:40 p.m.·
Tags:
Global TB response
The Senate State Foreign Operations Subcommittee approved a fiscal year 2015 funding bill Tuesday with no new resources for the U.S. flagship global AIDS program, PEPFAR, and an $11 million cut in the U.S. response to global tuberculosis. PEPFAR is funded at $4.02 billion and TB at $225 million. The Global Fund for AIDS, Tuberculosis and Malaria receives $1.35 billion in the bill for the fiscal year beginning October 1.
Read More →
By
Mark Mascolini
Published: June 17, 2014, 11:45 p.m.·
Tags:
HIV coinfection
A symptom-based tuberculosis screening questionnaire recommended by the World Health Organization (WHO) for people with HIV performed poorly in detecting TB and excluding pulmonary TB in South Africans taking antiretroviral therapy (ART). The symptom screen performed adequately in HIV-positive people not taking antiretrovirals.
Read More →
By
TB Europe Coalition
Published: June 17, 2014, 9:03 p.m.·
Tags:
Global TB response,
Advocacy
A national TB coalition was established last week in Macedonia, the first of this kind in Southeastern Europe. The coalition aims to increase collaboration between civil society organisations (CSOs) working in the field of TB prevention and control. Working as an informal platform, it will help the preparation of a comprehensive plan for financial sustainability of TB and HIV service by contributing to define priorities in the provision of TB services and ensuring integration and coordination of activities offered by CSOs.
Read More →
By
José Castro
Published: June 17, 2014, 8:47 p.m.·
Tags:
Treatment,
Access,
Drug-resistant TB,
Public health
Janssen Pharmaceuticals, a subsidiary of Johnson and Johnson, has announced that it will make its breakthrough new tuberculosis (TB) drug, Sirturo, available at a discount in 130 developing countries. As the first new antibiotic to be approved to treat TB in over 40 years, Sirturo will be an important new weapon in the aging arsenal of medicines used to treat this deadly disease.
Read More →
Page 633 of 878 · Total posts: 10
←First
632
633
634
Last→